放射線療法による低塩分症の治療のための現在の基礎的および臨床前研究
Olga J Baker1,2,3, Harim Tavares Dos Santos4, Kihoon Nam1,3
1Department of Otolaryngology-Head and Neck Surgery, University of Missouri, Columbia, MO.
JADA foundational science
|August 29, 2025
まとめ
頭頸部がんの放射線治療は 低塩分化を引き起こし 口腔の健康に影響します このレビューでは,唾液腺の機能を回復し,患者の生活の質を改善するための新しい治療法に関する研究が検討されています.
科学分野:
- 腫瘍学
- 再生医療
- 口腔 衛生
背景:
- 頭頸部がんに対する放射線治療 (RT) はしばしば低塩分化を引き起こし,口腔の健康状態を悪化させ,生活の質を低下させます.
- 唾液代用剤のような 現在の治療法は一時的な救済しか与えず,有害な影響を及ぼすことがあります.
研究 の 目的:
- 放射線による低塩分症の治療戦略に関する研究をレビューし,解釈する.
- 既存のアプローチを統合し,将来の開発分野を特定する.
主な方法:
- PubMed,MEDLINE,およびGoogle Scholar (2000-2024) で包括的な文献検索が行われました.
- 放射線治療後の唾液腺分泌機能の促進に関する研究が選択されました.
- アプローチは,治療のタイミング (RT前または後),治療目標,方法,研究段階によって分類された.
主要な成果:
- このレビューは,唾液腺の機能を回復することを目的とした一連の治療戦略をまとめています.
- アプローチは,最も研究されたものから最も研究されていないものまでの連続に沿って提示されます.
- 各治療法の主なメリットとデメリットについて説明します.
結論:
- このレビューは,放射線誘発性低塩分症の治療に関する研究を要約しています.
- この発見は,より永続的で効果的な臨床的解決法の開発を容易にするものです.
- 癌患者の唾液腺機能を改善するためのさらなる研究が推奨されています.
さらに関連する動画
関連する概念動画
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
321
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
321
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
259
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
259
Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Salivary Glands and Saliva
949
The salivary glands, of which there are three pairs known as the parotid, submandibular, and sublingual glands, play a crucial role in maintaining oral health and initiating the digestive process. Positioned near the ears, beneath the masseter muscle, the parotid glands secrete saliva into the oral cavity through the parotid duct of Stensen. Meanwhile, the submandibular glands, located on the floor of the mouth, secrete saliva through channels named submandibular ducts. The sublingual glands,...
949
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
366
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
366
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
439
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
439


